Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
Kelley, R.K., Nimeiri, H.S., Munster, P.N., Vergo, M.T., Huang, Y., Li, C.-M., Hwang, J., Mulcahy, M.F., Yeh, B.M., Kuhn, P., Luttgen, M.S., Grabowsky, J.A., Stucky-Marshall, L., Korn, W.M., Ko, A.H., Bergsland, E.K., Benson, A.B., Venook, A.P.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K
Published in British journal of cancer (01.10.2013)
Published in British journal of cancer (01.10.2013)
Get full text
Journal Article
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
KO, A. H, HWANG, J, VENOOK, A. P, ABBRUZZESE, J. L, BERGSLAND, E. K, TEMPERO, M. A
Published in British journal of cancer (25.07.2005)
Published in British journal of cancer (25.07.2005)
Get full text
Journal Article
A phase II study of axitinib in advanced neuroendocrine tumors
Strosberg, J R, Cives, M, Hwang, J, Weber, T, Nickerson, M, Atreya, C E, Venook, A, Kelley, R K, Valone, T, Morse, B, Coppola, D, Bergsland, E K
Published in Endocrine-related cancer (01.05.2016)
Published in Endocrine-related cancer (01.05.2016)
Get full text
Journal Article
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
Ducker, G S, Atreya, C E, Simko, J P, Hom, Y K, Matli, M R, Benes, C H, Hann, B, Nakakura, E K, Bergsland, E K, Donner, D B, Settleman, J, Shokat, K M, Warren, R S
Published in Oncogene (20.03.2014)
Published in Oncogene (20.03.2014)
Get full text
Journal Article
Transcatheter pulmonic valve replacement in carcinoid heart disease
Heidecker, B, Moore, P, Bergsland, E K, Merrick, S H, Rao, R K
Published in European heart journal cardiovascular imaging (01.09.2015)
Published in European heart journal cardiovascular imaging (01.09.2015)
Get more information
Journal Article
A phase I trial of the combination of temsirolimus (TEM) and sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)
Kelley, R. K., Nimeiri, H. S., Vergo, M. T., Bergsland, E. K., Ko, A. H., Munster, P. N., Reinert, A., Mulcahy, M. F., Benson, A. B., Venook, A. P.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Late vascular complications from hepatic artery infusional chemotherapy catheters
Ruan, D., Zuraek, M., Bergsland, E. K., Venook, A. P., O'Neill, D., Warren, R. S.
Published in Annals of surgical oncology (01.02.2004)
Published in Annals of surgical oncology (01.02.2004)
Get full text
Journal Article
Biliary stent complications in clinical trials for advanced pancreatic cancer
Espinoza, A. M., Ko, A. H., Ostroff, J. W., Venook, A. P., Bergsland, E. K., Kelley, R. K., Dito, E., Ong, A., Tempero, M. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase II, multicenter, randomized, double-blind, placebo-controlled, ascending, multidose, U.S. study of oral LX1606 (aka LX1032) in patients with refractory symptomatic carcinoid syndrome
Kulke, M., O'Dorisio, T. M., Phan, A. T., Langdon, R. M., Marek, B. J., Iklaque, N., Bergsland, E. K., Freiman, J., Frazier, K., Jackson, J., Zambrowicz, B.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II trial of figitumumab in patients with refractory, metastatic colorectal cancer (mCRC)
Becerra, C., Salazar, R., Garcia-Carbonero, R., Thomas, A. L., Vázquez-Mazón, F., Cassidy, J., Maughan, T., Gallén, M., Iveson, T., Hixon, M., Gualberto, A., Yin, D., Bergsland, E. K., Li, D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase I study, with expanded cohort, of biweekly fixed-dose rate gemcitabine (FDR GEM) plus capecitabine (CAP) in patients with advanced pancreatic (APC) and biliary carcinomas (ABC)
Espinoza, A. M., Ko, A. H., Venook, A. P., Bergsland, E. K., Jones, K. A., Kelley, R. K., Korn, W. M., Dito, E., Ong, A., Tempero, M. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Phase I trial of temsirolimus (TEM) plus sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)
Kelley, R. K., Nimeiri, H. S., Vergo, M. T., Chia, K., Mulcahy, M. F., Bergsland, E. K., Ko, A. H., Munster, P. N., Benson, A. B., Venook, A. P.
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
Phase I first-in-human study of the PI3 kinase inhibitor GSK2126458 (GSK458) in patients with advanced solid tumors (study P3K112826)
Munster, P. N., van der Noll, R., Voest, E. E., Dees, E. C., Tan, A. R., Specht, J. M., Falchook, G. S., Daud, A., Lolkema, M. P., Grilley-Olson, J. E., Yu, E. Y., Fu, S., Bergsland, E. K., Kleha, J., Peng, S., Smith, D. A., Lampkin, T. A., Schellens, J. H. M., Morris, S. R., Kurzrock, R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II trial of FOLFOX plus bevacizumab in advanced, progressive neuroendocrine tumors
Venook, A. P., Ko, A. H., Tempero, M. A., Uy, J., Weber, T., Korn, M., Bergsland, E. K.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase II study of bevacizumab (BEV) plus erlotinib (ERL) in patients with gemcitabine (GEM)-refractory metastatic pancreatic cancer (MPC)
Ko, A. H., Dito, E., Schillinger, B., Venook, A. P., Bergsland, E. K., Korn, W. M., Tempero, M. A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase II study of gemcitabine (GEM) given at fixed-dose rate (FDR) infusion, low-dose cisplatin (CDDP), and bevacizumab (BEV) for metastatic adenocarcinoma of the pancreas (PanCa): Update with completion of study accrual
Ko, A. H., Dito, E., Schillinger, B., Venook, A. P., Bergsland, E. K., Wong, D., Allen, J., Tempero, M. A.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Phase 1 trial of metronomic cyclophosphamide (CTX), bevacizumab (BV) and imatinib (IM) in patients (pts) with advanced solid tumors
Bergsland, E. K., Ko, A. H., Tempero, M. A., Whittaker, K., Weber, T., Fong, L., Park, J. W., Yeh, B. M., Hanahan, D., Venook, A. P.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article